Since incorporating the p16INK4A immunohistochemistry and histopathologic diagnosis examination improves diagnosis of the cervical intraepithelial neoplasia (CIN), p16INK4A immunohistochemistry was assessed as the gold standard for defining the efficiency of cervical cancer screening methods (12). This evidence concerns the gene CDKN2A and cervical cancer.